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PURPOSE. The purpose of this study was to compare retinal nerve fiber layer (RNFL) thickness
and optical coherence tomography angiography (OCT-A) retinal vasculature measurements in
healthy, glaucoma suspect, and glaucoma patients.
METHODS. Two hundred sixty-one eyes of 164 healthy, glaucoma suspect, and open-angle
glaucoma (OAG) participants from the Diagnostic Innovations in Glaucoma Study with good
quality OCT-A imageswere included. Retinal vasculature information was summarized as a vessel
density map and as vessel density (%), which is the proportion of flowing vessel area over the
total area evaluated. Two vessel density measurements extracted from the RNFL were analyzed:
(1) circumpapillary vessel density (cpVD) measured in a 750-lm-wide elliptical annulus around
the disc and (2) whole image vessel density (wiVD) measured over the entire image. Areas under
the receiver operating characteristic curves (AUROC) were used to evaluate diagnostic accuracy.
RESULTS. Age-adjusted mean vessel density was significantly lower in OAG eyes compared with
glaucoma suspects and healthy eyes. (cpVD: 55.1 6 7%, 60.3 6 5%, and 64.2 6 3%,
respectively; P < 0.001; and wiVD: 46.2 6 6%, 51.3 6 5%, and 56.6 6 3%, respectively; P <
0.001). For differentiating between glaucoma and healthy eyes, the age-adjusted AUROC was
highest for wiVD (0.94), followed by RNFL thickness (0.92) and cpVD (0.83). The AUROCs for
differentiating between healthy and glaucoma suspect eyes were highest for wiVD (0.70),
followed by cpVD (0.65) and RNFL thickness (0.65).
CONCLUSIONS. Optical coherence tomography angiography vessel density had similar diagnostic
accuracy to RNFL thickness measurements for differentiating between healthy and glaucoma
eyes. These results suggest that OCT-A measurements reflect damage to tissues relevant to the
pathophysiology of OAG.
Keywords: glaucoma, OCT angiography, RNFL
The potential role of the microvasculature and blood flow inthe pathophysiology of glaucoma, a progressive optic
neuropathy1, has been debated and extensively investigat-
ed.2–10 Previous studies have demonstrated reduced ocular
blood flow in optic nerve head, retina, choroid, and retrobulbar
circulations in glaucoma.5,7,9,11–19 However, the lack of a
reproducible and relevant in vivo quantitative assessment
method has limited the study of both ocular perfusion11,20
and their microvascular networks.
Radial peripapillary capillaries (RPCs) comprise a distinct
network of capillary beds located within the retinal nerve fiber
layer (RNFL) that supply the retinal ganglion cell (RGC)
axons.21–24 Although histologic studies highlighted the impor-
tance of the RPC networks in glaucoma,25–27 in vivo
investigations have been limited by the lack of a technique to
quantitatively characterize the microvasculature.28 A reliable
clinical method for imaging these vascular beds would improve
our knowledge about the role of RPCs in RGC axonal health
and disease.29
In this regard, optical coherence tomography angiography
(OCT-A) is a new imaging modality that can be used to
characterize vasculature in various retinal layers,30 providing
quantitative assessment of the microcirculation in the optic
nerve head31,32 and peripapillary region.33 The objective of the
current study is to assess the performance of OCT-A retinal
vessel density measurements for differentiating among healthy
subjects, glaucoma suspects, and glaucoma patients and also to
compare its diagnostic accuracy to spectral-domain (SD)-OCT
RNFL thickness measurements.
METHODS
Study Population
This was an observational cohort study of healthy subjects,
glaucoma suspects, and open-angle glaucoma (OAG) patients
enrolled from the Diagnostic Innovations in Glaucoma Study
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(DIGS) who completed OCT-A imaging (AngioVue; Optovue,
Inc., Fremont, CA, USA)30,31,33,34 and optic nerve head imaging
using SD-OCT (Avanti; Optovue, Inc.).
The DIGS protocol and eligibility criteria have been
described in detail previously.35 In brief, all participants
underwent an ophthalmologic examination, including assess-
ment of best-corrected visual acuity, slit-lamp biomicroscopy,
intraocular pressure (IOP) measurement with Goldmann
applanation tonometry, gonioscopy, ultrasound pachymetry,
dilated fundus examination, simultaneous stereophotography
of the optic disc, and visual field testing. Inclusion criteria were
(1) greater than 18 years of age, (2) open-angles on gonioscopy,
and (3) best-corrected visual acuity (BCVA) of 20/40 or better.
Healthy subjects had (1) IOP <21 mm Hg with no history
of elevated IOP; (2) normal appearing optic disc, intact
neuroretinal rim, and RNFL; and (3) a minimum of two
reliable normal visual fields, defined as a pattern standard
deviation (PSD) within 95% confidence limits and a glaucoma
hemifield test (GHT) result within normal limits. Eyes were
classified as glaucomatous if they had repeatable glaucoma-
tous visual field damage defined as a GHT outside normal
limits and PSD outside 95% normal limits. Glaucoma suspects
were defined as having glaucomatous optic neuropathy or
suspicious appearing optic discs based on stereophotograph
reviewed by two experienced graders and/or ocular hyper-
tension (IOP > 21 mm Hg) without evidence of repeatable
glaucomatous visual field damage. The diagnostic category for
each participant was determined based on the diagnosis of his
or her worse eye.
Participants with a history of intraocular surgery (except for
uncomplicated cataract surgery or glaucoma surgery), coexist-
ing retinal pathologies, nonglaucomatous optic neuropathy,
uveitis, or ocular trauma were excluded from the study.
Participants were also excluded if there was a diagnosis of
Parkinson’s disease, Alzheimer’s disease, dementia, or a history
of stroke. Participants with systemic hypertension and diabetes
mellitus were included unless they were diagnosed with
diabetic or hypertensive retinopathy. Participants having
unreliable visual field, poor quality OCT-A, or optic nerve
head SD-OCT scans were also excluded from our study.
Systemic measurements included two blood pressure (BP)
measurements obtained using an Omron Automatic (Model
BP791IT; Omron Healthcare, Inc., Lake Forest, IL, USA) blood
pressure instrument. Mean arterial pressure was calculated as
one-third systolic BP þ two-thirds diastolic BP. Mean ocular
perfusion pressure (MOPP) was defined as the difference
between two-thirds of mean arterial pressure and IOP. Optical
coherence tomography angiography and SD-OCT images were
obtained by the same operator and at the same visit using the
AngioVue, which is a dual modality OCT system. The AngioVue
is an angiographic platform implemented on an existing
commercially available SD-OCT platform. The AngioVue
imaging system is able to provide structural measurements
and vascular measurements.
Informed consent was obtained from all participants, and all
methods adhered to the tenets of the Declaration of Helsinki
and the Health Insurance Portability and Accountability Act
and were approved by the Institutional Review Boards at the
University of California San Diego.
Standard Automated Perimetry
Standard automated perimetry visual field tests were complet-
ed using Swedish Interactive Threshold Algorithm standard 24-
2 (Humphrey Field Analyzer; Carl Zeiss Meditec, Dublin, CA,
USA) strategies. The quality of the visual fields was reviewed by
the Visual Field Assessment Center (VisFACT) staff. Only
reliable tests (33% fixation losses and false-negative errors
and 15% false-positive errors) and visual fields without rim
and eyelid artifacts, evidence of inattention or fatigue effects,
and no evidence that the abnormal results of the visual field
were caused by a disease other than glaucoma, were included.
Visual field result was considered to be abnormal if a GHT was
outside of normal limits or a PSD fell outside of the 95% normal
confidence limits.
Optical Coherence Tomography Angiography
Image Acquisition and Processing
The AngioVue provides a noninvasive OCT-based method for
visualizing the vascular structures of the retina. It uses an 840-
nm light source and has an A-scan rate of 70,000 scans/s and a
bandwidth of 50 nm. Each volume contains 3043 304 A-scans
with two consecutive B-scans captured at each fixed position.
Each volume scan is acquired in 3 seconds and consists of two
orthogonal volumes that are used to minimize motion artifacts
arising from microsaccades and fixation changes. The split-
spectrum amplitude-decorrelation angiography (SSADA) meth-
od was used to capture the dynamic motion of the red blood
cells and provide a high-resolution 3D visualization of perfused
retinal vasculature.30
The AngioVue characterizes vascular information at various
user-defined retinal layers as a vessel density map and
quantitatively as vessel density (%) (Fig. 1). Vessel density
was automatically calculated as the proportion of measured
area occupied by flowing blood vessels defined as pixels
having decorrelation values acquired by the SSADA algorithm
above the threshold level.
For this report, we analyzed vessel density in the
peripapillary RNFL in images with a 4.5 3 4.5-mm field of
view centered on the optic disc. Vessel density within the
RNFL was measured from internal limiting membrane (ILM) to
RNFL posterior boundary using standard AngioVue software
(version 2015.1.0.90). Measurements were obtained in two
areas. Whole enface image vessel density (wiVD) was
measured in the entire 4.5 3 4.5-mm image, and circum-
papillary vessel density (cpVD) was calculated in the region
defined as a 750-lm-wide elliptical annulus extending from the
optic disc boundary (Fig. 1).
Image quality review was completed on all scans according
to a standard protocol established by the University of
California, San Diego Imaging Data Evaluation and Analysis
(IDEA) Reading Center. Trained graders reviewed scans and
excluded poor quality images, defined as images with (1) a
signal strength index of less than 48, (2) poor clarity, (3)
residual motion artifacts visible as irregular vessel pattern or
disc boundary on the enface angiogram, (4) local weak signal,
or (5) RNFL segmentation errors. The location of the disc
margin was reviewed for accuracy and adjusted manually if
required.
Spectral-Domain OCT Imaging
All subjects also underwent optic nerve head imaging with a
commercially available SD-OCT system (Avanti) with a70-kHz
axial line rate, 840-nm central wavelength, a 22-lm focal spot
diameter, and an axial resolution of 5 lm in tissue.
The optic nerve head (ONH) map protocol was used to
obtain RNFL thickness measurements; RNFL measurements
were calculated in a 10-pixel-wide band along a circle of
3.45 mm in diameter centered on the ONH. Only good-
quality images, as defined by scans with a signal strength
index ‡37, and without segmentation failure and artifacts
were included. The overall average RNFL thickness was used
in this analysis.
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Statistical Analysis
The distribution of numerical data was tested for normality
using the Shapiro-Wilk test. Descriptive statistics were
calculated as the mean and standard deviation for normally
distributed variables and median, first quartile, and third
quartile for nonnormally distributed variables. Categorical
variables were compared using the v2 test. Age-adjusted
ANOVA was used for the comparison between groups, and
the Tukey-Kramer honest significant difference (HSD) post hoc
test was performed to adjust for multiple comparisons
between groups within each analysis.
Diagnostic accuracy for differentiating between (1) healthy
and glaucoma eyes and (2) healthy and glaucoma suspect eyes
was evaluated by calculating the area under the receiver
operating characteristic (AUROC) curves. For the analysis of
vessel density, each participant contributed eyes to either the
glaucoma patient group or the glaucoma suspect group, but
not both. If both eyes of a glaucoma patient did not show
evidence of repeatable visual field damage, then the eye
without visual field damage was excluded from the analyses of
both the glaucoma eyes and glaucoma suspect eyes.
For completeness, diagnostic accuracy also was calculated
for differentiating between (1) healthy subjects and glaucoma
patients and (2) healthy subjects and glaucoma suspect
participants using the mean vessel density of both eyes as
the unit of analysis for each subject.
The AUROC curves were adjusted for age differences
between groups, using a covariate adjustment regression
method.36,37 For the analysis by eye, a between-cluster
variance estimator was used to adjust for including both eyes
of the same subject in the model.
Pairwise comparisons of the AUROCs were performed using
the method suggested by Pepe al.36 to evaluate whether there
were statistically significant differences between the ROC
curves. All statistical analyseswere performedwith commercially
available software a Stata version 14 (StataCorp, College Station,
TX, USA) and JMP version 11.2.0 (SAS, Inc., Cary, NC, USA). The
a level (type I error) was set at 0.05 for all comparisons.
RESULTS
Two hundred sixty-one eyes of 164 healthy subjects, glaucoma
suspects, and OAG patients with good-quality scans were
included in the analysis. Mean age in the healthy group was
significantly lower than both glaucoma and glaucoma suspect
group (P < 0.001; Table 1). Therefore, all comparisons and ROC
curves were adjusted for age differences between groups.
Compared with glaucoma suspect and healthy subjects,
FIGURE 1. Retinal nerve fiber layer vessel density map in healthy, glaucoma suspect, and open-angle glaucoma eyes. Top row: circumpapillary vessel
density map measurement region defined. Middle row: vessel density extracted map overlay on the major retinal vessels. Bottom row: area vessel
density color-coded map.
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glaucoma patients had significantly lower IOPs (P < 0.001 and P
¼ 0.042, respectively), and they had also thinner central corneas
compared with the glaucoma suspect group (P¼ 0.040).
There were no statistically significant differences between
systolic, diastolic, mean BP and mean ocular perfusion pressure
measurements among groups. However, self-reported history of
hypertension was more frequent in glaucoma patients and
glaucoma suspects compared with healthy controls (P¼ 0.006).
Statistically significant differences were found between
glaucoma patients and healthy subjects for all ocular parameters
except for disc area. Visual fieldmean deviation and PSDwere not
significantly different between glaucoma suspects and healthy
controls (P ¼ 0.819 and P ¼ 0.870, respectively). However,
glaucoma suspects had on average thinner RNFL and smaller rim
areas compared with healthy subjects (P < 0.05 for both).
Age-adjusted 1-way ANOVAs showed that the vessel density
values were significantly different among the three groups (P <
0.001 for both wiVD and cpVD). The wiVD values were
significantly lower in glaucoma eyes (46.2%), followed by
glaucoma suspect eyes (51.3%) and healthy eyes (56.6%); all
three pairwise comparisons were statistically significant
(Tukey-Kramer HSD, P < 0.05 for all comparisons). For cpVD,
the pairwise comparisons showed that glaucoma eyes (55.1%)
had significantly lower cpVD values compared with both
glaucoma suspects eyes (60.3%) and healthy eyes (64.2%)
(Tukey-Kramer HSD, P < 0.001 for both). However, there was
TABLE 1. Demographic and Ocular Characteristics of Healthy Subjects, Glaucoma Suspects, and Glaucoma Patients
Variables
Healthy,
n ¼ 23
Glaucoma Suspect,
n ¼ 37
Glaucoma,
n ¼ 104 P Value
Demographic characteristics
Age, y† 53.5 (47.8, 60.2) 68.2 (61.7, 76.3) 72.4 (64.7, 80.8) <0.001*
Sex, male/female 14/9 23/14 55/49 0.546
Ethnicity, AD/ED 7/16 11/26 28/76 0.913
Clinical characteristics
Systolic blood pressure, mm Hg† 123.5 (108.8, 138.5) 123.0 (115.5, 136.0) 126.5 (117.0, 136.8) 0.401
Diastolic blood pressure, mm Hg† 79.5 (68.0, 89.5) 79.0 (72.0, 88.0) 77.0 (70.0, 83.0) 0.416
Mean blood pressure, mm Hg‡ 95.0 6 13.5 94.4 6 10.0 94.4 6 11.0 0.973
MOPP, mm Hg‡ 52.9 6 8.9 52.0 6 7.5 54.1 6 7.5 0.328
Heart rate, beats/min‡ 71.0 6 10.0 69.0 6 11.2 67.0 6 11.8 0.333
Self-reported history of diabetes, n (%) 1 (4.4%) 5 (13.5%) 15 (14.4%) 0.339
Self-reported history of hypertension, n (%) 5 (21.7%) 20 (55.0%) 60 (57.7%) 0.006*
Diabetes medications, n (%) 1 (4.4%) 1 (2.7%) 10 (9.6%) 0.321
Antihypertensive medications, n (%) 4 (17.4%) 12 (32.4%) 47 (45.2%) 0.011*
Topical glaucoma medications, n (%) 0 (0.0%) 27 (73.0%) 87 (83.7%) <0.001*
Ocular characteristics (mean of both eyes is reported)
IOP, mm Hg*† 15.5 (13.5, 18.0) 15.5 (13.0, 20.8) 14.0 (11.0, 16.0) <0.001*
CCT, lm*‡ 544.2 6 38.5 549.4 6 43.4 530.6 6 37.8 0.035*
Disc area, mm2† 1.9 (1.6, 2.2) 1.9 (1.8, 2.5) 2.0 (1.7, 2.4) 0.445
Rim area, mm2‡ 1.3 6 0.3 1.1 6 0.3 0.8 6 0.3 <0.001*
Visual field mean deviation, dB† 0.2 (0.3, 0.7) 0.4 (1.2, 0.1) 3.9 (8.8, 1.8) <0.001*
Visual field pattern standard deviation, dB† 1.5 (1.3, 1.8) 1.8 (1.5, 2.3) 4.6 (2.7, 8.9) <0.001*
AD, African descent; ED, European descent; MOPP, mean ocular perfusion pressure; IOP, intraocular pressure; CCT, central corneal thickness.
* Statistical significance tested by ANOVA for normal distributions and Kruskal-Wallis tests for nonnormal distributions, all comparisons were
corrected with post hoc test.
† Nonnormally distributed variables; represented by median (interquartile range).
‡ Normally distributed variables; represented by mean (6SD).
TABLE 2. Age-Adjusted Mean Values and Diagnostic Accuracy (AUROC) for OCT-A Vessel Density and Spectral-Domain OCT RNFL Thickness
Measurements in Healthy Participants, Glaucoma Suspects, and Glaucoma Patients
Diagnostic
Parameters
Healthy Eyes
Mean (95% CI),
n ¼ 44
Glaucoma
Suspect Eyes
Mean (95% CI),
n ¼ 55
Glaucoma Eyes
Mean (95% CI),
n ¼ 124 P Value
AUROC (SE)
Glaucoma Eyes
Versus Healthy Eyes
AUROC (SE)
Glaucoma Suspect
Eyes Versus
Healthy Eyes
OCT-A whole image
vessel density, % 56.6 (55.7–57.4) 51.3 (50.0–52.6) 46.2 (45.2–47.2) <0.001*†‡§ 0.94 (0.03) 0.70 (0.10)
OCT-A circumpapillary
vessel density, % 64.2 (63.2–65.2) 60.3 (59.1–61.6) 55.1 (54.0–56.3) <0.001*†§ 0.83 (0.06) 0.65 (0.10)
SD-OCT average RNFL
thickness, lm 99.4 (96.3–102.4) 88.4 (84.9–91.8) 74.5 (72.1–76.9) <0.001*†‡§ 0.92 (0.03) 0.65 (0.09)
* Statistical significance tested by ANOVA, corrected with post hoc test.
† Significant difference between mean values of glaucoma and healthy subjects.
‡ Significant difference between mean values of glaucoma suspect and healthy subjects.
§ Significant difference between mean values of glaucoma and glaucoma suspect subjects.
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no significant difference in cpVD between glaucoma suspect
and healthy eyes (P ¼ 0.426; Table 2; Fig. 2).
Overall, the AUROC6 SE for discriminating between healthy
and glaucomatous eyes was highest for wiVD (0.94 6 0.03),
followed by RNFL (0.92 6 0.03) and cpVD (0.83 6 0.06).
Pairwise comparisons showed that the age-adjusted AUROC of
wiVD (0.94) was higher than cpVD (0.83) (P < 0.05), and their
diagnostic accuracies were similar to RNFL thickness (0.92) (P>
0.05 for both) for differentiating between glaucoma and healthy
eyes (Table 2; Fig. 3). The AUROC for differentiating between
FIGURE 2. Boxplots illustrating the distribution of whole image vessel density (top), circumpapillary vessel density (middle), and average retinal
nerve fiber layer thickness (bottom) measurements in healthy, glaucoma suspect, and glaucoma eyes. The medians are represented by horizontal
line in the gray box. Error bars denote interquartile range.
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glaucoma suspect eyes from healthy eyes was highest for wiVD
(0.70 6 0.10), followed by RNFL thickness (0.65 6 0.09) and
cpVD (0.65 6 0.10). These differences in AUROC did not reach
statistical significance (Table 2; Fig. 4).
Similar analyses were completed comparing healthy sub-
jects and glaucoma patients and healthy subjects and glaucoma
suspect patients using the mean of both eyes in the analysis.
Overall, the AUROC 6 SE for discriminating between healthy
and glaucomatous participants was highest for wiVD (0.87 6
0.05), followed by RNFL thickness (0.87 6 0.04) and cpVD
(0.71 6 0.08). The AUROC for differentiating between healthy
and glaucoma suspects was highest for wiVD (0.70 6 0.11),
followed by cpVD (0.62 6 0.10) and RNFL thickness (0.62 6
0.09).
DISCUSSION
In the current study, we demonstrated that OCT-A vessel
density measured in the RNFL, the most superficial layer of the
retina, distinguishes among groups of glaucoma, glaucoma
suspect, and healthy participants. Specifically, wiVD performs
as well as RNFL thickness for discriminating between healthy
and glaucoma patients and for differentiating between the
healthy and glaucoma suspect groups. The wiVD also had
significantly better diagnostic accuracy than cpVD for differ-
entiating between glaucoma patients and healthy groups.
In the present study, the diagnostic accuracy of vessel
density measurements were evaluated for differentiating
glaucoma eyes from healthy eyes, as well as glaucoma patients
from healthy subjects. Regardless of whether the analysis was
completed with the participant as the unit of analysis or
whether the eye was the unit of analysis, the same conclusion
was drawn; vessel density measures have similar diagnostic
accuracy as RNFL thickness for glaucoma and glaucoma
suspect detection. However, compared with the analysis with
participant as the unit of analysis, the AUROC with eyes as the
unit of analysis had larger AUROC values (0.87 and 0.94,
respectively) because the analysis by participant included the
mean of both eyes in the analysis, regardless of whether the
fellow eye had visual field damage.
These results are consistent with previous reports that
showed differences in OCT-A microvasculature between
glaucoma and healthy groups in the optic disc31,34 and
peripapillary region.33 However, these reports assessed both
the superficial and deep capillary beds and calculated the
vascular parameters in a thicker retinal slab from the ILM to the
RPE. To our knowledge, this is the first study using OCT-A to
evaluate the microvascular bed in the RNFL layer, which largely
reflects the RPCs.
These findings that OCT-A vessel density measurements and
OCT-based RNFL thickness measurements have a similar
AUROC for glaucoma detection are also consistent with other
studies reporting high AUROC for both peripapillary vessel
density measures in a thicker slab from ILM to RPE and SD-OCT
RNFL thickness measurements (AUROCs, 0.94 and 0.97,
respectively).33
Although structural measurements, such as RNFL and optic
nerve head parameters (rim, cup, etc.), have been shown to be
associated with disc size,38 to the best of our knowledge, no
studies evaluated the effect of disc size on vessel density
measurements. In the current study, there was no significant
correlation between disc area and wiVD and cpVD measure-
ments in healthy eyes (r ¼ 0.04, P ¼ 0.815 and r ¼ 0.01, P ¼
0.474, respectively). For this reason, disc area was not
controlled for in the analyses.
In the current study, it also was found that wiVD performs
as well as RNFL thickness for discriminating between glaucoma
suspect eyes and healthy controls, with AUROCs 6 SE of 0.70
6 0.10 and 0.65 6 0.09, respectively (P ¼ 0.497). There is
evidence that RNFL thinning is detectable in ocular hyperten-
sive eyes39,40 and preperimetric glaucomatous eyes41 even
before morphologic changes of the optic disc become visible
and visual field defects occur. There is also evidence that
changes in the blood flow are detectable in glaucoma suspects
with no visual field defect.42 However, the ability of OCT-A to
FIGURE 3. Area under the receiver operator characteristic curves for
whole image vessel density (0.94), circumpapillary vessel density
(0.83), and average RNFL (0.92), for differentiating between glaucoma
eyes and healthy eyes.
FIGURE 4. Area under the receiver operator characteristic curves for
whole image vessel density (0.70), circumpapillary vessel density
(0.65), and average RNFL (0.65) for differentiating between glaucoma
suspect eyes and healthy eyes.
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discriminate between glaucoma suspects and healthy subjects
has not been reported previously.
An unexpected finding in the current study was the
significantly better diagnostic accuracy of wiVD compared
with cpVD for differentiating between healthy and glaucoma
groups. There are several possible explanations for this result.
First, the larger measurement area has the advantage of
detecting changes in the RPCs, the RNFL capillary plexus,
which is an additional superficial vascular bed accompanying
axons that extend eccentrically along the temporal vessels.43 In
contrast to RNFL thickness assessment that measures virtually
all ganglion cell axons as they exit the eye at the optic nerve,
measuring cpVD may not fully capture the presence of most of
the RPCs. In this regard, there is no consensus on their origin.
Some studies suggest that RPCs originate from retinal vessels in
the ganglion cell layer and arch up abruptly to supply the
RNFL,44 whereas others report that they originate from the
optic disc.43 There is, however, consensus regarding the
anatomy of the RPCs; these distinct elongated microvascular
networks run parallel to the RGC axons and are more
prominent in the peripheral arcuate RNFL region.45 Therefore,
the larger measurement area of the wiVD may, at least in part,
explain the better performance of these measurements
compared to cpVD. As suggested in Figure 1, vessel dropout
is visible qualitatively in all areas of the image, including the
periphery outside the measurement area of cpVD. Thus, the
limited measurement size of cpVD may not include regions of
sparse vasculature that are of diagnostic value.
Finally, because the study population comprises a high
proportion of early glaucoma patients, the larger measurement
area may be detecting early vessel dropout associated with
focal RNFL damage in early glaucoma that is more apparent in
the peripapillary retina farther from the circumpapillary region
included in cpVD.46
Impairment of blood flow in the optic nerve and
peripapillary retina in glaucoma patients is well document-
ed.16,18 However, not all studies found significant differences in
the blood flow of the neuroretinal rim47 and peripapillary
area12,48,49 between glaucoma patients and healthy controls.
Results of studies relating ocular blood flow to glaucoma are
difficult to compare due to the variety of techniques applied,
different parameters of ocular hemodynamics investigated, and
differences in glaucoma populations studied.
Measurement of ocular blood flow has been challenging,
and it should be noted that OCT-A does not directly measure
blood flow. A number of methods have been used to document
differences in blood flow between glaucoma and normal eyes,
but none have been appropriate for routine clinical use.20 The
high variability of Doppler flowmetry and laser speckle
flowgraphy measurements,33,50 the limited resolution with
MRI, and invasive nature and time intensiveness of fluorescein
angiography4,6,51 limit their ability to provide information on
vascular components that contribute to the pathophysiology of
glaucoma.
Doppler OCT52 has been used for measuring total retinal
blood flow, with a better level of precision than other Doppler
methods.53 However, this technique is only able to assess flow
in larger retinal vessels and does not provide information on
the microvascular networks, which is of primary interest in
glaucoma.34
The RNFL is largely comprised of the axons of RGCs, one of
the most metabolically active cells in human.54 These cells
have tremendous metabolic requirements and depend on
regional capillary networks to meet them. Despite the critical
role of RNFL capillary plexus relative to glaucomatous damage
suggested by several investigators,21,25,27,55 our previous
inability to quantify microvascular network features29 has
prevented evaluation of the clinical characteristics of the RNFL
capillary beds and obtaining a more comprehensive under-
standing of the RGC axonal damage in glaucoma. Based on the
results of the current study, we hypothesize that OCT-A
provides a new imaging target for early diagnosis and
management of glaucoma. Clearly, longitudinal data are needed
to evaluate this possibility.
There are several limitations to the current study. First, the
healthy participants were significantly younger than the
glaucoma suspects and glaucoma patients. For this reason, all
analyses were adjusted for age. Moreover, it is unlikely that the
main finding that vessel density measures performed as well as
RNFL thickness for differentiating between healthy and
glaucoma participants would be affected by the age of the
healthy controls, as the same subjects are used in all analyses.
In addition, due to the cross-sectional, noninterventional
design of the study, it was not possible to evaluate the
potentially confounding impact of ocular hypotensive eye
drops and BP-lowering medications on vascular measurements.
Most participants in the glaucoma (83.7%) and glaucoma
suspect (73.0%) groups were treated using ocular antihyper-
tensive medications at the time of OCT-A imaging. Further,
41.3% of glaucoma patients and 35.2% glaucoma suspects were
taking multiple ocular antihypertensive medications. It also
should be noted that in the present study patients were not
excluded based on systemic conditions or systemic medication
in order to better reflect the general population. As outlined in
Table 1, 45.2% of glaucoma patients, 32.4% of glaucoma
suspects, and 17.4% of healthy participants with self-reported
history of hypertension were taking antihypertensive medica-
tions. Therefore, we could not rule out the impact of systemic
conditions and systemic medications on vessel density
measurements. Further studies are needed to address the
influence on OCT-A measurements of ocular hypotensive
treatment and systemic medications more specifically. Finally,
it was not possible to characterize the causal relationship
between altered vessel density and glaucomatous damage.
Therefore, longitudinal studies are needed to elucidate the
temporal relationship between retinal vascular change and
glaucomatous optic neuropathy.
The current study demonstrated that OCT-A vessel density
is lower in glaucoma patients compared with healthy controls
and glaucoma suspects and has a similar diagnostic accuracy
to RNFL thickness for discriminating healthy subjects from
glaucoma suspects and glaucoma patients. This study is
unique in that it compared the diagnostic accuracy of OCT-A
measures and standard SD-OCT RNFL thickness for discrim-
inating between healthy, glaucoma suspect, and glaucoma
patients. The ability of OCT-A to noninvasively evaluate the
capillary networks shows promise for characterizing glau-
comatous retinal vascular changes and may have a role in
glaucoma management. Longitudinal studies are needed to
determine whether a lower vessel density found in glaucoma
patients precedes or follows optic nerve damage and whether
this information can be used to improve glaucoma manage-
ment.
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